Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK [IMGN632]) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
Stanford University
Fred Hutchinson Cancer Center
University of Alabama at Birmingham
M.D. Anderson Cancer Center
Hackensack Meridian Health
City of Hope Medical Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
City of Hope Medical Center
University of Chicago
Therapeutic Advances in Childhood Leukemia Consortium
Washington University School of Medicine
City of Hope Medical Center
St. Jude Children's Research Hospital
Northwestern University
University of Illinois at Chicago
Medical College of Wisconsin
Medical College of Wisconsin
St. Jude Children's Research Hospital
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
University of Kentucky
New Approaches to Neuroblastoma Therapy Consortium
New Approaches to Neuroblastoma Therapy Consortium
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
PETHEMA Foundation
Emory University
M.D. Anderson Cancer Center
University of Pittsburgh
University of Illinois at Chicago
Institut du Cancer de Montpellier - Val d'Aurelle
M.D. Anderson Cancer Center
Swiss Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fred Hutchinson Cancer Center
Northwestern University
Washington University School of Medicine
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota